Company Files
You are here: Home » About Us » Company Files

About Us: Discover Loncom Pharma's Expertise & Vision

Research Field

Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan. Loncom Pharma is a high-tech enterprise integrating drug research and development, production and technical services.

The company has four major technology platforms: API R&D Platform, Formulation R&D Platform, Biological Sample Analysis Platform and Impurity Research Platform.It adheres to the R&D spirit of "Being rigorous, serious, focused and realistic", and takes ICH international guidelines as the standard to accumulate in the development of formulations and APIs continuously. At present, the company's products have covered cardiovascular and cerebrovascular system, digestive system, anti-tumor, nervous system, geriatric medicine, andrology medicine, pediatric medicine and other fields.

About LONCOM Pharm - Mirabegron, Lacosamide Supplier

The company has established the QA and QC system in line with C-GMP, which is equipped with advanced testing instruments and equipment, such as high performance liquid chromatography, gas chromatography, ion chromatography, X-ray diffraction analyzer, Malvern laser particle size instrument, automatic dissolution instrument, total organic carbon analyzer, etc.A professional information management system (LIMS) is introduced as well, It reaches the industry's advanced level in knowledge management and data management, which lays a solid foundation for creating high-quality and high-standard drugs.
 
The company focus on the production of specialty APIs and has the manufacturing capability to supply APIs to the world; The formulation workshop adopts an automated production system to realize the efficiency, intelligence and standardization of formulation production, which can produce tablets, granules, capsules, dry suspensions, oral liquid preparations and other dosage forms. Loncom Pharma has three API production workshops GMP certified by the state, as well as three production lines for tablets, hard capsules, dry suspensions and oral liquid preparations.
high-tech enterprise specializing in pharmaceutical R&D, production, and technical service

Our Advantage

Over the past decade, Loncom has cultivated a rich cultural heritage and developed a unique brand competitiveness. With the corporate mission of "Pharmaceutical Innovation for the Benefit of Humanity", the company remains committed to social responsibility and its mission, joining hands with other great enterprises in the field to safeguard the noble mission of promoting human health.​​​​​​​

Loncom Pharma

Adhering to the production concept of "Safety, Environmental Protection, Quality and Efficiency", the company takes safe production and environmental protection as its own responsibility, strictly abides by the bottom line of safety and environmental protection, cares for the occupational health of employees, and realizes the harmonious unity of man and the environment. The company has passed the international certification of occupational health and safety management system, environmental management system (ISO14001) and safety production standardization system (ISO45001).
high-tech enterprise specializing in pharmaceutical R&D, production, and technical service

Company Culture


Development Course

  • May. 2012
    • Shandong Loncom Pharmaceutical Co., Ltd. is founded.
  • Aug. 2012
    • Shandong Loncom Pharmaceutical Co., Ltd. holds a groundbreaking ceremony.
  • Apr. 2014
    • Shandong Loncom Pharmaceutical Co., Ltd. obtains the "Drug Manufacturing License".
  • Aug. 2015
    • Shandong Loncom Pharmaceutical Co., Ltd. obtains the first API approval letter- "Registration Certificate for Rosuvastatin Calcium".
  • Dec. 2015
    • Rosuvastatin Calcium API passes GMP inspection without defects.
  • Jan. 2018
    • Shandong Loncom Pharmaceutical Co., Ltd. obtains EHS Certificate.
  • May. 2020
    • Shandong Loncom Pharmaceutical Co., Ltd. obtains the first MAH - "Registration Certificate for Ramivudine Tablets".
  • Dec. 2020
    • Shandong Loncom Pharmaceutical Co., Ltd. passes the national high-tech enterprise certification.
  • Apr. 2022
    • Lacosamide Oral Solution is approved as the first generic.
  • Dec. 2022
    • Lacosamide API obtains CEP certificate.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.

QUICK LINKS

PRODUCT CATEGORY

Copyright © 2023 Shandong Loncom Pharmaceutical Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy
Supported by leadong.com
Contact Us